Advances in Wound Care and Healing Technology

Wounds are unique in so far as no disease process other than wounds would have existed from the beginning of mankind. Over the years, the management of wounds, especially that of chronic wounds, has had enormous social and economic implications worldwide. With an aging population, this impact is likely to increase. In recent years, this has been reflected by the birth and rapid growth of the new speciality of ‘wound healing’.Continuous advances made in the study of the wound microenvironment, an ever-broadening understanding of the pathophysiology of wounds, and improved techniques in monitoring the response of healing have led to continuing developments in the treatment of chronic wounds. Current research focuses on growth factors and human skin substitutes that provide promising results. This article reviews advances made in wound care management over the years. Despite all these advances, it must be borne in mind that basic principles of wound care in a multidisciplinary team setting still remain the backbone of wound management.

[1]  S. Ibbotson,et al.  Randomised trial of oral aspirin for chronic venous leg ulcers , 1994, The Lancet.

[2]  H Green,et al.  Treatment of skin ulcers with cultured epidermal allografts. , 1989, Journal of the American Academy of Dermatology.

[3]  A. Layton,et al.  The effect of aspirin on haemostatic activity in the treatment of chronic venous leg ulceration , 1995, The British journal of dermatology.

[4]  J. Niinikoski Effect of oxygen supply on wound healing and formation of experimental granulation tissue. , 1969, Acta physiologica Scandinavica. Supplementum.

[5]  A. Andrews,et al.  The use of larval therapy in wound management. , 1998, Journal of wound care.

[6]  S. Badylak,et al.  Identification of extractable growth factors from small intestinal submucosa , 1997, Journal of cellular biochemistry.

[7]  D. Foreman,et al.  Control of scarring in adult wounds by neutralising antibody to transforming growth factor β , 1992, The Lancet.

[8]  D. Foreman,et al.  Neutralising antibody to TGF-beta 1,2 reduces cutaneous scarring in adult rodents. , 1994, Journal of cell science.

[9]  D. Steed,et al.  Effect of extensive debridement and treatment on the healing of diabetic foot ulcers. Diabetic Ulcer Study Group. , 1996, Journal of the American College of Surgeons.

[10]  V. Falanga,et al.  Growth factors and wound healing. , 1993, Clinics in dermatology.

[11]  S. Arnoczky,et al.  Use of small intestinal submucosal implants for regeneration of large fascial defects: an experimental study in dogs. , 1999, Journal of biomedical materials research.

[12]  E. A. Wright,et al.  An Antibiotic from Maggots , 1957, Nature.

[13]  I. Shannon,et al.  A clinical report. Water-free stannous-fluoride gel and post-irradiation caries. , 1972, Journal of public health dentistry.

[14]  K. O'Dea The prevalence of pressure damage in acute care hospital patients in the UK. , 1999, Journal of wound care.

[15]  E. Chantelau,et al.  Antibiotic Treatment for Uncomplicated Neuropathic Forefoot Ulcers in Diabetes: a Controlled Trial , 1996, Diabetic medicine : a journal of the British Diabetic Association.

[16]  P. Molan The role of honey in the management of wounds. , 1999, Journal of wound care.

[17]  E. Coyle,et al.  Infection control properties of some wound dressings. , 1999, Journal of wound care.

[18]  Richard A.F. Clark,et al.  The Molecular and Cellular Biology of Wound Repair , 2012, Springer US.

[19]  A. Graham The use of growth factors in clinical practice. , 1998, Journal of wound care.

[20]  G. Harris,et al.  A Comparison Study of Plantar Foot Pressure in a Standardized Shoe, Total Contact Cast, and Prefabricated Pneumatic Walking Brace , 1997, Foot & ankle international.

[21]  R. Tompkins,et al.  Genetically modified human epidermis overexpressing PDGF-A directs the development of a cellular and vascular connective tissue stroma when transplanted to athymic mice--implications for the use of genetically modified keratinocytes to modulate dermal regeneration. , 1995, The Journal of investigative dermatology.

[22]  J. Smiell,et al.  Efficacy and Safely of a Topical Gel Formulation of Recombinant Human Platelet-Derived Growth Factor-BB (Becaplermin) in Patients With Chronic Neuropathic Diabetic Ulcers: A phase III randomized placebo-controlled double-blind study , 1998, Diabetes Care.

[23]  S. Rose,et al.  Diabetic plantar ulcers treated by total contact casting. A clinical report. , 1987, Physical therapy.

[24]  I. Naylor Ulcer care in the Middle Ages. , 1999, Journal of wound care.

[25]  L. Vistnes,et al.  Proteolytic activity of blowfly larvae secretions in experimental burns. , 1981, Surgery.

[26]  T. K. Hunt,et al.  Regulation of wound-healing angiogenesis-effect of oxygen gradients and inspired oxygen concentration. , 1981, Surgery.

[27]  T. K. Hunt,et al.  The effect of varying ambient oxygen tensions on wound metabolism and collagen synthesis. , 1972, Surgery, gynecology & obstetrics.

[28]  E. Eriksson,et al.  In vivo transfer and expression of a human epidermal growth factor gene accelerates wound repair. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[29]  A. Naylor,et al.  A prospective randomised trial of four-layer versus short stretch compression bandages for the treatment of venous leg ulcers. , 1998, Annals of the Royal College of Surgeons of England.

[30]  P. Prete,et al.  Growth effects of Phaenicia sericata larval extracts on fibroblasts: mechanism for wound healing by maggot therapy. , 1997, Life sciences.

[31]  C. Ruckley,et al.  New porcine dermis dressing for varicose and traumatic leg ulcers. , 1976, British medical journal.

[32]  Paul Martin,et al.  Wound Healing--Aiming for Perfect Skin Regeneration , 1997, Science.

[33]  C. Hammarlund,et al.  Hyperbaric oxygen reduced size of chronic leg ulcers: a randomized double-blind study. , 1994, Plastic and reconstructive surgery.

[34]  P. Sheffield Tissue oxygen measurements with respect to soft tissue wound healing with normobaric and hyperbaric oxygen , 1985 .

[35]  M. Robson,et al.  Wound Infection: A Failure of Wound Healing Caused by an Imbalance of Bacteria , 1997 .

[36]  G. Winter,et al.  Formation of the Scab and the Rate of Epithelization of Superficial Wounds in the Skin of the Young Domestic Pig , 1962, Nature.

[37]  P. Jones,et al.  Oxpentifylline treatment of venous ulcers of the leg. , 1990, BMJ.

[38]  M. Ferguson,et al.  Fetal Wound Healing and the Development of Antiscarring Therapies for Adult Wound Healing , 1988 .

[39]  I Eltringham,et al.  Mupirocin resistance and methicillin-resistant Staphylococcus aureus (MRSA). , 1997, The Journal of hospital infection.

[40]  E. Shaw,et al.  Absence of bacterial resistance to povidone iodine. , 1976, Journal of clinical pathology.

[41]  D. Margolis,et al.  Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Human Skin Equivalent Investigators Group. , 1998, Archives of dermatology.

[42]  N. Cullum,et al.  A systematic review of laser therapy for venous leg ulcers. , 1999, Journal of wound care.

[43]  G. A. Holloway,et al.  Randomized Prospective Double-Blind Trial in Healing Chronic Diabetic Foot Ulcers: CT-102 activated platelet supernatant, topical versus placebo , 1992, Diabetes Care.

[44]  G. A. Holloway,et al.  Systemic treatment of venous leg ulcers with high doses of pentoxifylline: efficacy in a randomized, placebo‐controlled trial , 1999, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[45]  F. Cerra,et al.  Stimulation of repair in chronic, nonhealing, cutaneous ulcers using platelet-derived wound healing formula. , 1990, Surgery, gynecology & obstetrics.

[46]  R. Ross,et al.  The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum. , 1975, The American journal of pathology.

[47]  E. A. Nelson,et al.  Randomised, double blind placebo controlled trial of pentoxifylline in the treatment of venous leg ulcers , 1999, BMJ.

[48]  S. Moberg,et al.  A Randomized Trial of Cadexomer Iodine in Decubitus Ulcers , 1983, Journal of the American Geriatrics Society.

[49]  D. Foreman,et al.  Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. , 1995, Journal of cell science.

[50]  L. Klenerman,et al.  Neuropathic foot ulceration treated by total contact casts. , 1992, The Journal of bone and joint surgery. British volume.